<DOC>
	<DOCNO>NCT02412449</DOCNO>
	<brief_summary>The primary purpose study compare PK parameter single dose test tablet formulation AKB-6548 relative single dose reference AKB-6548 tablet formulation , treatment administer without food , compare PK parameter test tablet formulation give fed fasted condition .</brief_summary>
	<brief_title>Relative Bioavailability Two Formulations AKB-6548 Food Effect New Tablet Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject 18 55 year age , inclusive , body mass index 18 30 kg/m2 , inclusive . Current past history cardiovascular , cerebrovascular , pulmonary , renal liver disease . Positive serology result HBsAg , HCV , HIV Screening . Significant renal impairment evidence estimate glomerular filtration rate ( eGFR ) &lt; 65 mL/min Known active cancer ( except nonmelanoma skin cancer ) history chemotherapy use within previous 24 month . Current past history gastric duodenal ulcer diseases GI tract ( include gastric bypass surgery ) could interfere absorption study drug . Subjects know history smoking and/or use nicotine nicotinecontaining product within past 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Anemia</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>CKD</keyword>
	<keyword>Renal impairment</keyword>
	<keyword>Chronic renal insufficiency</keyword>
	<keyword>Ferrous sulfate</keyword>
	<keyword>Iron</keyword>
	<keyword>End stage renal disease</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Oral anemia treatment</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>Hypoxia-inducible factor</keyword>
	<keyword>Volunteers</keyword>
</DOC>